🇺🇸 FDA
Pipeline program

Buprenorphine soluble film

RB-US-07-0002

Phase 2 small_molecule completed

Quick answer

Buprenorphine soluble film for Opioid-related Disorders is a Phase 2 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid-related Disorders
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials